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Abstract
Mutants in presenilins (PS1 or PS2) is the major cause of Familial Alzheimer’s disease (FAD). 
FAD causing PS mutants affect intracellular Ca2+ homeostasis by enhancing the gating of inositol 
trisphosphate (IP3) receptor (IP3R) Ca2+ release channels on the endoplasmic reticulum, leading to 
exaggerated Ca2+ release into the cytoplasm. Using experimental IP3R-mediated Ca2+ release 
data, in conjunction with a computational model of cell bioenergetics, we explore how the 
differences in mitochondrial Ca2+ uptake in control cells and cells expressing FAD-causing PS 
mutants affect key variables such as ATP, reactive oxygen species (ROS), NADH, and 
mitochondrial Ca2+. We find that as a result of exaggerated cytosolic Ca2+ in FAD-causing mutant 
PS-expressing cells, the rate of oxygen consumption increases dramatically and overcomes the 
Ca2+ dependent enzymes that stimulate NADH production. This leads to decreased rates in proton 
pumping due to diminished membrane potential along with less ATP and enhanced ROS 
production. These results show that through Ca2+ signaling disruption, mutant PS leads to 
mitochondrial dysfunction and potentially to cell death.
Introduction
Alzheimer’s disease (AD) is a form of dementia that is characterized by extensive synaptic 
and neuronal loss which leads to impaired memory and cognitive decline. Most AD cases 
are sporadic (SAD) and account for a large population of AD patients, but about 10% are 
inherited (FAD) and develop as early as the age of 30 as a result of mutations in amyloid 
precursor protein (APP) or presenilins (PS1, PS2) [5, 20]. Both SAD and FAD share the 
features of accumulated extra-and intracellular β-amyloid plaques, intracellular 
neurofibrillary tangles composed mostly of hyperphosphorylated tau protein, and cell 
atrophy and death in multiple brain regions [18, 25, 38]. Both types of AD share similar 
phenotypes, suggesting a common pathogenic origin. However, mechanisms for how these 
proteins create such devastating effects in the neuron are still unclear.
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PS are transmembrane proteins that are synthesized on the endoplasmic reticulum (ER) [1]. 
PS forms a protein complex that is transported to the cell surface where it functions as a γ-
secretase that cleaves type 1 transmembrane proteins, including APP [10]. The cleavage of 
APP releases Aβ peptides, which is a major component of amyloid plaques in the brains of 
patients with AD. These mutant PSs are thought to affect APP processing by increasing the 
production of amyloidogenic Aβ. Besides the disruption of APP processing, FAD-linked PS 
mutants dysregulate intracellular Ca2+ homeostasis [5, 6, 24]. PS mutants inuence 
intracellular Ca2+ signaling by means of exaggerated Ca2+ release from the ER through the 
inositol 1,4,5-trisphosphate (IP3) receptor (IP3R), the main intracellular Ca2+ release channel 
in non-excitable cells [5, 6, 19, 26, 39–41]. The Ca2+ hypothesis of brain aging and AD first 
proposed by Khatchaturian [23] suggests that over time, Ca2+ handling of neurons becomes 
compromised, leading to excessive free intracellular Ca2+ concentration ([Ca2+]i) and 
reactive oxygen species (ROS), mitochondrial dysfunction, and eventually apoptosis. 
Increasing data suggests that neuronal Ca2+ dysregulation plays a critical role in AD 
pathogenesis [3, 42].
Mitochondria is responsible for the production of ATP, which is driven by the TCA cycle 
and oxidative phosporylation. It is generally believed that mitochondria can function as a 
dynamic Ca2+ sequestration system [36]. Ca2+ plays a crucial role in facilitating the 
communication between mitochondria and other components of the cell [34]. Ca2+ has been 
shown to activate the mitochondrial matrix dehydrogenases in the TCA cycle [12, 30] and 
inuence the supply of NADH and FADH2, thereby affecting the oxidative phosphorylation 
and the amount of ATP produced in the matrix. Thus, irregularities in mitochondrial Ca2+ 
homeostasis can cause severe complications to cellular physiological functions including 
bioenergetics.
Cheung et al. [5] observed that FAD-causing PS mutants lead to gain-of-function 
enhancement of IP3R Ca2+ release channels. This gain-of-function enhancement at the 
single channel level leads to high-frequency, high-amplitude whole-cell Ca2+ oscillations in 
FAD-causing PS mutants-expressing cells as compared to control cells expressing wild-type 
(WT) PS1.
Here we investigate how these high frequency and high amplitude [Ca2+]i oscillations impair 
mitochondrial function in cells expressing PS mutants. We achieve this by feeding 
experimental whole cell [Ca2+]i time traces directly into a computational model that takes 
into consideration the TCA cycle, oxidative phosphyorilation, Ca2+ dynamics, and ROS 
production. We compare the mitochondrial function in a cell with PS mutant-induced Ca2+ 
signals to that in a control cell. We show that the increased Ca2+ uptake in the mitochondria 
due to exaggerated Ca2+ release through IP3R in FAD causing PS1 mutant-expressing cells 
leads to decreased ATP production, increased ROS in mitochondria ( ) and [H2O2], 
which over time can lead to cell death. The cells that we study are representatives of all the 
observations in [5] and the conclusions apply to all experiments in that study.
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Materials and Methods
Experimental Methods
Intracellular Calcium Recordings—Whole-cell recordings obtained using fluorescence 
Ca2+ imaging of intracellular Ca2+ signals in human B lymphocytes elicited by exposure to 
human IgM, as reported in [5], were used in this study. We compare the Ca2+ signals in 
human lymphocytes expressing FAD-causing M146L mutant PS derived from FAD patients 
to signals in control lymphocytes expressing WT PS derived from normal individuals to 
investigate the impact of mutation in PS on various mitochondrial functions.
Computational Methods
Our model incorporates mitochondrial physiological processes such as the tricarboxylic acid 
(TCA) cycle, oxidative phosphorylation, Ca2+ signaling pathways, and ROS dynamics. We 
adopted the computational model from Cortassa et al. [7], which was modified from the 
work done by Magnus and Keizer [28]. The main components in our model are shown in 
Figure 1. Rate equations for variables are given in Table S1 and their corresponding 
parameters and fluxes are described in the supporting information.
The model developed by Magnus and Keizer describes Ca2+ handling by mitochondria in the 
pancreatic β-cell. The Magnus and Keizer model includes 6 transport mechanisms in the 
inner mitochondrial membrane: proton pumping due to respiration, proton pumping uptake 
by the F1F0 – ATPase, a proton leak, the adenine nucleotide exchanger, the Ca2+ uniporter, 
and the Na+/Ca2+ exchanger. The original Magnus and Keizer model also includes dynamic 
changes in mitochondria membrane potential (ΔΨm), ADP ([ADP]m), and Ca2+ 
concentration ([Ca2+]m) by means of 3 rate equations. The Magnus and Keizer model was 
expanded by Fall and Keizer [16] to include coupling with Ca2+ release through IP3R based 
on the De Young-Keizer model that describes the properties of Ca2+ release from the ER 
through IP3R channels [11]. In the Fall and Keizer model, Ca2+ released from the ER is 
sequestered into mitochondria through the Ca2+ uniporter [16]. The Fall and Keizer model 
was then expanded to include the mitochondria permeability transition pore (PTP) [13, 34].
Missing in these studies is a mechanism through which Ca2+ regulates the TCA cycle and 
ROS production dynamics that is dependent upon oxygen consumption of the mitochondria. 
The work done by Cortassa et al. [7, 8] includes TCA cycle dehydrogenases that drive 
NADH production, and ROS production due to a shunt of electrons from the electron 
transport chain. The Cortassa et al. model is a 16 variable model and shows that when Ca2+-
sensitive dehydrogenases are the main rate-controlling steps of respiratory flux, there are 
significant increases in oxygen consumption (Vo2), proton efflux, NADH, and ATP 
synthesis. The Cortassa et al. model is able to reproduce experimental data concerning 
mitochondrial bioenergetics, Ca2+ dynamics, and respiration control [7]. Thus, we choose 
this model for our study although other expansions of the Magnus-Keizer model are also 
available in the literature [22, 31, 32].
Our main goal in this study, is to combine experimental Ca2+ release from whole-cell 
cytosolic data from [5] and the Cortassa et al. model to compare the differences in 
mitochondrial bioenergetics in the absence and presence of PS mutant-induced exaggerated 
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IP3R-mediated cytosolic Ca2+ release. We remark that our conclusions about the impairment 
of mitochondrial function in the presence of PS-mutants qualitatively remain the same 
irrespective of the model selection. In the following we describe the key components of the 
model. The full details and equations of the model are given in supporting information.
TCA Cycle—Isocitrate ([ISOC]), α-ketoglutarate ([αkg]), succinyl CoA ([SCoA]), 
succinate ([Suc]), fumarate ([FUM]), malate ([MAL]), and oxalacetate ([OAA]) are all 
chemical intermediates involved in the TCA cycle. The enzymes generating or processing 
these entities in the TCA cycle are citrate synthase (CS), aconitase (ACO), isocitrate 
dehydrogenase (IDH), alpha-ketoglutarate dehydrogenase (KGDH), succinyl CoA lyase 
(SL), succinate dehydrogenase (SDH), fumarate hydratase (FH), malate dehydrogenase 
(MDH), and aspartate amino transferase (AAT). The rate equations of the reactions 
catalyzed by these enzymes are shown in the supporting material. The TCA cycle provides a 
pathway for substrate oxidation. The cycle completes the oxidation of AcCoA to CO2 and 
produces NADH and FADH2. The TCA cycle enzymes isocitrate dehydrogenase (IDH) and 
alpha ketoglutarate dehydrogenase (KGDH) have explicit dependence on [Ca2+]m. The 
coefficients of the TCA cycle equations were determined in [7, 28], and can be viewed in 
Table S2 and S3.
Oxidative Phosphorylation—The oxidative phosphorylation equations are based on 
Cortassa et al. [7] and Magnus and Keizer model [28]. Both models describe the NADH-
driven electron transport, proton efflux, F1F0 – ATPase activity, and the influx of protons. 
Ares, AF1, and ΔμH are driving forces for the oxidative phosphorylation that correspond to 
redox potential, phosphorylation potential, and proton motive force. The coefficients in the 
equations are given in Table S4 and S5.
Mitochondrial Ca2+ Dynamics—Ca2+ influx and efflux are conducted mainly by Ca2+ 
uniporter and the Na+/Ca2+ exchanger respectively [7, 28]. The Na+/Ca2+ exchanger is set to 
be electrogenic based on the parameters given by [28]. Equations governing the influx and 
efflux rates can be found in the supporting material and rate parameters for the equations are 
given in Table S6.
ROS Production—ROS is modeled as a shunt of electrons from the electron transport 
chain (ETC) into the matrix. Mitochondrial ROS generation is considered a side path for 
electrons diverging from the ETC [8]. Rate equations governing the production of ROS are 
given in Table S7 and their corresponding fluxes are given in the supporting material.
Numerical Methods—Numerical integration of the model equations was performed with 
Intel Fortran compiler (Intel Corporation, Santa Clara, CA). ODEs were solved using RK4 
method. Code producing key results in the paper is available upon request from authors.
Results
In the results we compare mitochondrial TCA cycle, oxidative phosporylation, Ca2+ 
dynamics, and ROS production derived from whole-cell uorescence Ca2+ imaging 
measurements from control cells (CTL) and cells expressing FAD-causing PS mutant- 
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M146L [5]. The parameters for Figures 2–4 can be found in Tables S2–S8. We then show 
how the total amount of mitochondrial ATP ([ATP]), [Ca2+]m, [H2O2], ROS in cytoplasm 
, and [NADH] change as we vary rates of adenine nucleotide translocator 
(VmaxANT), the mitochondrial uniporter (Vmuni), and mitochondria Na+/Ca2+ exchanger rate 
(Vnacamax). We choose these rates because they directly inuence mitochondrial Ca2+ 
dynamics and ATP production. Other rates did not significantly change mitochondrial 
bioenergetics and are not shown.
Inuence of cytoplasmic Ca2+ on mitochondria over time
In Cheung et al. [5], IP3R-mediated Ca2+ release in human B-lymphoblats cells from 
individuals with various PS mutants (FAD lymphoblasts) and individuals with wild type PS 
(control lymphoblasts) were compared. IP3R in control lymphoblasts had low channel open-
probability (Po) ranging from 0.18±0.02 to 0.23±0.03 [5]. These channel activities are 
associated with brief openings and relatively long closings. Po of IP3R channels in FAD B-
lymphoblats was substantially higher at 0.81±0.02.
To determine if this observed higher Po affects [Ca2+]i signals, IP3R-mediated whole-cell 
Ca2+ signals in B-lymphoblasts were measured with uorescence Ca2+ imaging. Control B-
lymphoblasts showed spontaneous low frequency and low amplitude Ca2+ oscillations. In 
contrast, FAD lymphoblasts exhibited exaggerated spontaneous Ca2+ signals showing high 
frequency and high amplitude Ca2+ oscillations. Both the fraction of active cells exhibiting 
Ca2+ oscillations and the frequency of the oscillations doubled in FAD cells relative to 
control cells [5]. In this study, we selected a representative control (CTL) cell and a cell 
expressing the M146L mutant of PS (M146L-expressing) studied in [5] to evaluate the 
effects of this exaggerated Ca2+ signaling on mitochondrial function. However, the main 
conclusions in this paper should be applicable to all the observations in [5].
The influence on mitochondrial physiological processes due to changes in [Ca2+]i was 
examined by combining the experimental time traces for [Ca2+]i with our computational 
model as described in the supporting material. Figure 2 shows the time trace of all the state 
variables tracked in the model, excluding the TCA cycle which is shown in Figure 3. Figure 
2 shows the time series of the CTL (blue lines) and M146L-expressing cells (red) [Ca2+]i 
and its effect on [Ca2+]m, [NADH], [H2O2], , [ATP], and ΔΨm. As observed 
previously [5], the M146L-expressing cell shows elevated Ca2+ signals that oscillate at a 
higher frequency and amplitude than the control cells (Figure 2A). The observed [Ca2+]i 
shows how the higher Po of IP3R due to PS mutants affects whole cell Ca2+ signals as 
compared to the control cell. The mitochondrial Ca2+ uptake simulated using our model is 
shown in Figure 2B. Mitochondria buffers [Ca2+]i as [Ca2+]i oscillates, and the M146L-
expressing cells show an elevated increase in total [Ca2+]m over time as compared to the 
control cell. Total amount of Ca2+ in the cytoplasm and Ca2+ uptake by mitochondria over 
the 30 min simulation was calculated by integrating over the full duration of the experiment. 
In the cytoplasm, there is 33% more IP3R-mediated Ca2+ release which leads to 66% more 
Ca2+ uptake by the mitochondria in M146L-expressing cell compared to the control cell 
according to our simulations.
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Figure 2C shows the simulated NADH production over the 30 minutes for both cell types. 
As we discuss further in Figure 4, the sharp decreases in the [NADH] correspond to the high 
amplitude oscillations in [Ca2+]i because Vo2 exceeds the NADH production rates of the 
three enzymes (VIDH, VKGDH, and VMDH).
In Figures 2D–F we show the variables related to the ROS production in the model. In this 
case, all parameters in the tables were kept such that the  would not exceed the critical 
value beyond which the VIMAC would open, releasing ROS to the cytoplasm and 
depolarizing ΔΨm. The limit on  was imposed to keep the IMAC channel closed 
because we are interested in the total amount of , rather than its downstream effects. 
As a consequence, [H2O2] and  stay relatively low throughout the duration of the 
simulation. Though the [H2O2] and  show little differences between the two cell types 
because of the reasons noted above, the  shows a noticeable difference following the 
spiking of [Ca2+]i. The  is positively correlated with Vo2 based on the percentage of 
oxygen consumption that is partitioned for producing . In this case, 4.8% of total 
oxygen consumption is used for , as shown by the shunt parameter in Table S8. Thus, 
as Vo2 increases with the high concentration of [Ca2+]m, the  increases along with it. 
Figure 2G shows the [ATP] production over 30 min of simulation. The sharp declines in 
ATP production that correspond to the oscillations in [Ca2+]i are due to the decreases in 
NADH production during oscillations. Figure 2H shows depolarization of ΔΨm due to 
increases in oxygen consumption that decreases the rate of H+ transport across the 
membrane.
Ca2+ driven TCA cycle
We are interested in how the perturbations in the cytosolic Ca2+ signals affect the 
bioenergetics of the mitochondria. Denton and McCormack demonstrated that Ca2+ 
stimulated mitochondrial matrix dehydrogenase, which increased electron supply to the 
respiratory chain and thus the rates of the respiration [12, 30]. To analyze the complete 
picture and the time evolution of the levels of intermediate products of the TCA cycle, we 
evaluated the dehydrogenase activity throughout the duration of the experiment (Figure 3). 
In this model, KGDH and IDH are directly stimulated by Ca2+ imported into the matrix 
through uniporter. Thus in Figure 3A, the production of ISOC is negatively affected by Ca2+ 
because it is regulated by IDH, which is responsible for catalyzing the oxidative 
decarboxylation of ISOC into αkg. As ISOC catalyzes the third step of the TCA cycle and 
converts NAD to NADH, [αkg] is formed. [αkg] is regulated by enzymes IDH, KGDH and 
AAT. KGDH is much more dependent on the influx of Ca2+ and since KGDH catalyzes the 
conversion between αkg and SCoA, the higher [Ca2+]m (Figure 2B) leads to a steeper drop 
in [αkg] (Figure 3B). Figure 3C–G shows the rest of the TCA cycle dehydrogenases activity. 
The rates of key enzymes (VIDH, VKGDH, and VMDH) are what drive the production of 
NADH and hence the oxidative phosphorylation of the mitochondria shown in Figure 4.
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Response of NADH and ATP production
Two interesting observations can be made from Figure 2. The total [NADH] (integrated over 
30 minutes) produced in the M146L-expressing cell during the 30 min experiment is greater 
than the CTL cell by about 3 mM but the [ATP] produced is 1 mM less than the control cell. 
Over time this can add up to catastrophic differences. What is most interesting is that while 
the PS mutant-expressing cell produces a larger amount of [NADH], which drives oxidative 
phosphorylation, it produces less [ATP]. In Figure 2, at the troughs of [Ca2+]i oscillations, 
there are rapid declines in [NADH] and [ATP], as much as 5 μM and 6 μM, respectively. The 
reason behind this behavior, is given below.
Ca2+ affects the bioenergetics of the mitochondria in two opposing ways. Ca2+ influx 
diminishes ΔΨm, which will decrease the proton motive force. While this is happening, Ca2+ 
stimulates the production of NADH, which increases the proton motive force (ΔμH) and ATP 
production. In the following, we show that the influx of Ca2+ drives ΔμH down, while the 
rise in Vo2 overcomes the rates of the enzymes producing NADH that drive oxidative 
phosphorylation. As shown in Figure 4, when the rate of oxygen consumption and NADH 
driving enzymes oscillate at high amplitude according to the influx of Ca2+, there are times 
when Vo2 surpasses the enzymes which saturate according to Michaelis-Menten kinetics. 
This will decrease the production of NADH as seen in Figure 2. Since the production of ATP 
is heavily dependent upon the NADH production, we see a decline in ATP at these instances 
according to the rate of the F1F0 – ATPase. This is observed in Figure 4C–D where the rate 
of F1F0 – ATPase decreases when the Vo2 surpasses the rate of the NADH producing 
enzymes. This occurrence is much more pronounced in the M146L-expressing cells as 
[Ca2+]i oscillates at a higher amplitude and frequency, driving the [NADH] lower more 
frequently, subsequently leading to decreased ATP production by the mitochondria.
Changing maximal rates of enzymes involved in NADH production increases the difference 
of overall production of key variables considerably
In the following, we investigate the maximum rates of VmaxANT, Vunimax, and Vnacamax and 
their affects on the total [ATP], [Ca2+]m, [H2O2], , and [NADH] in both CTL 
and M146L-expressing cells. The results were obtained by determining the total amount of 
these entities by integrating the relevant variable over 30 minutes in CTL cells (TotalCTL) 
and M146L-expressing cells (TotalML). The differences (TotalML-TotalCTL) are plotted 
against each of the maximum rates as shown in Figures 5–7. Apart from VmaxANT, Vunimax, 
or Vnacamax, all other parameters were held fixed as given in Tables S2–S8.
The rate of the adenine nucleotide translocator (ANT)—The adenine nucleotide 
translocator (ANT) is responsible for the transfer of [ATP] and cytosolic ADP ([ADP]i) 
across the inner membrane. As in [4, 7, 28], we consider the ANT to be electrogenic and 
dependent on the gradient of ATP and ADP. It is important to understand how the rate of 
ANT serves the mitochondria in transporting ADP and ATP across the inner membrane. 
This exchange is not only important to the mitochondria as it brings in ADP, but also for the 
whole cell as it releases ATP to energize various cellular physiological processes.
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Figure 5A shows the difference in total ATP production as a function of VmaxANT. The 
mitochondria in CTL cell produce more ATP than those in M146L-expressing cell and the 
difference increases with decreasing VmaxANT. At VmaxANT close to 0, representing a severe 
dysfunction in the mitochondrial ANT, the difference in production is nearly 5 mM; and as 
the VmaxANT increase to a normal rate, there is still a difference of 3.5 mM in total ATP 
production over a 30 minute duration. As the ANT rate slows down, no ATP can escape 
from the matrix, leading to an ATP build up in the mitochondria and lower values of ADP 
influx to drive the proton pumping across the membrane. Figure 5B shows how 
mitochondrial Ca2+ buffering changes as we increase VmaxANT. As VmaxANT increases, 
increasing the influx of ADP, the total difference in amount of Ca2+ in the matrix changes 
over a range of 83.4μM-84.2μM in 30 minutes. This is because increasing VANT makes 
ΔΨm more negative, thereby allowing more Ca2+ into the matrix. Figures 5C–E show the 
differences in total [H2O2], , and , and all of them increase in M146L-expressing 
cells over a 30 minute experiment. As the ANT rate increases, the [ADP]i/[ATP] ratio 
increases, which increases the respiration rate Vo2 [7], allowing more oxygen consumption 
for ROS production in the matrix. The difference of total  reaches 18mM for a fully 
functional ANT (Figure 5E). This constitutes a large difference in ROS production and has 
high potential for causing complications for the mitochondria in M146L-expressing cells. 
The [H2O2] and  difference continues to increase with increasing VmaxANT. This is 
because as the  production increases, the rate of transport of ROS across the inner 
mitochondrial membrane increases, which facilitates the transport of ROS to the cytoplasm. 
This increases the production of superoxide dismutase (SOD) which in turn increases 
[H2O2]. Figure 5F, which shows the difference in total [NADH] production, is somewhat 
misleading at first. It shows that mitochondria in the the M146L-expressing cell produces 
more NADH than those in CTL cells. This should lead to more ATP being produced by the 
M146L-expressing cell. But as Figure 5A shows, this is clearly not the case. The reason for 
this is the same as described in the previous section. Overall, more NADH may be produced 
because of the peaks shown in Figure 2C. But the rapid declines in NADH production are 
more pronounced because of the increased respiration rate, which lowers the rate of the F1F0 
– ATPase, and in turn lowers the ATP production by as much as 5mM.
Changing the rate of uniporter—The maximal rate of the mitochondrial Ca2+ uniporter 
(Vunimax) determines the rate of Ca2+ uptake into the matrix. Abnormal uniporter activity 
can alter Ca2+ buffering by mitochondria and lead to overall cell dysfunction.
Figure 6 shows that when Vunimax is close to 0, the uniporter is unable to bring much Ca2+ 
into the matrix to stimulate key driving factors in the matrix. This leads to small differences 
in [Ca2+]m, [ATP], [H2O2], , and [NADH] between CTL and M146L-expressing cells. 
However, even with a slow uniporter, a significant difference of over 8 mM in  is still 
observed. As the rate through the uniporter increases, we observe, for the most part, a near-
linear increase in the difference between all the key variables. With a maximal uniporter rate 
of 10mM/s, we observe that M146Lexpressing cells produce 3mM more NADH but 3mM 
less ATP than CTL cells. Also, the difference in  reaches 11mM.
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The rate of Na+/Ca2+ exchanger
The mitochondrial Na+/Ca2+ exchanger (VNaCa) is the main mechanism for Ca2+ efflux 
from the mitochondrial matrix and therefore plays a crucial role in maintaining Ca2+ 
homeostasis in the mitochondrial matrix.
As the maximal rate of the exchanger increases, thereby extruding more Ca2+ from the 
mitochondrial matrix, the difference in ATP production rapidly plateaus to about 1mM. This 
is because the exchanger uses a three step Altman-King-Hill process of binding 1 Ca2+ and 3 
Na+ for every exchange across the membrane, and [Na+] is constant. This is evident in 
Figure 7B, where the difference in [Ca2+]m rapidly saturates to a fixed value after VNaCa is 
increased beyond a certain value. As the exchanger rate decreases, the efflux of Ca2+ to the 
cytoplasm decreases, leaving more Ca2+ inside the matrix. The Vo2 rate then increases (see 
Figure 4) and ATP and NADH production declines as evident in Figure 7A and F, 
respectively. This explains why the values in Figure 7F becomes negative. The CTL cell’s 
mitochondria is able to produce more NADH as Ca2+ is unable to escape due to decreasing 
VNaCa rate. Since the [Ca2+]m difference increases, the [H2O2] and ROS production 
difference increases and eventually plateaus to  and 270 
μM ([H2O2]).
Discussion
In the AD brain, several pathophysiological events such as disruptions in Ca2+ homeostasis 
and mitochondrial bioenergetics resulting in cell dysfunction and apoptosis are known to 
occur [2, 9, 33]. Mitochondria is responsible for generating large amounts of ATP required 
for neurons to function properly, buffering Ca2+ in the synapses due to the abundance of 
Ca2+ channels and glutamatergic receptors, rapid uptake of Ca2+ released from the ER, and 
proper neurotransmission [9]. Mitochondria can also unleash a cascade leading to cell death 
[14]. Mitochondria dysfunction in AD is characterized by decreased cytochrome c oxidase 
(COX), increased ROS generation, and altered activity of the TCA cycle enzymes [14, 27]. 
Thus, elucidating key pathways leading to mitochondrial dysfunction in AD is crucial.
The main goal of this study is to fuse whole cell [Ca2+]i time traces from previous 
experiments [5] with a detailed computational model to investigate mitochondrial 
bioenergetics and how the differences in Ca2+ signals in control cells and cells expressing 
FAD-causing PS mutants affect several key variables regulated by mitochondria such as 
Ca2+ uptake, ROS, NADH, and ATP production. Our simulations show that mitochondria 
produces significantly less ATP and more ROS as a result of exaggerated [Ca2+]i in PS 
mutant-expressing cells. Furthermore, we tested a wide range of values of key parameters in 
the model (VmaxANT, Vunimax, and Vnacamax) that govern the ATP production and Ca2+ 
fluxes across the mitochondrial membrane for their effects on mitochondrial function in 
control and FAD cells.
Our model provides key insights into the relationship between ΔΨm, Vo2, and F1F0 – 
ATPase activity and allows us to better understand how overload of Ca2+ into the 
mitochondria leads to detrimental effects on cellular functions that are not easy to study 
experimentally. It has been established that accumulation of Ca2+ in the mitochondria can 
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cause membrane potential collapse, a rapid drop in ATP levels, and increase in ROS [17]. 
We show that high influx of Ca2+ into the mitochondria as a result of PS mutant-induced 
enhanced Ca2+ release through IP3Rs can diminish ATP production significantly. This is 
because IP3R-mediated Ca2+ release from the ER raises [Ca2+]i, thereby drive more Ca2+ 
influx into the mitochondrial matrix [7]. This has two opposing effects on mitochondria: (1) 
the activity of the TCA cycle dehydrogenases is stimulated (Figure 3), and (2) ΔΨm is 
dissipated. Our simulation (Figure 2H) clearly demonstrate that the dissipative effect is the 
predominate one in PS mutant-expressing cells.
In isolated mitochondria, Ca2+ stimulation can increase NADH production [30, 44], 
although the magnitude of this increase also depends on NADH oxidation [7]. Thus, there is 
an ongoing competition between the two opposing effects in the production of NADH. In 
both CTL and PS mutant-expressing cells, when the total enzyme rate overcomes Vo2, the 
flux of F1F0 – ATPase stays constant. However, during times of high Ca2+ influx, ΔμH is 
dissipated and Vo2 is faster, thereby reducing NADH production. When NADH production 
is diminished along with ΔμH, the redox potential that drives NADH-mediated proton 
pumping falls. Also, the increase in ADP contributes negatively to the phosphorylation 
potential and lowers the rate of F1F0 – ATPase. All these effects resulting from the sharp 
increases in [Ca2+]m stemming from high frequency, high amplitude [Ca2+]i oscillations 
contribute to diminished ATP production by the mitochondria.
ROS production in the mitochondria is considered a side path to diverge electrons from the 
normal electron transport chain [8], (see Figure 1). In the rate equation governing 
mitochondrial ROS production, it is clear that  depends on a shunt of the oxygen 
consumption. This together with the dissipative effects on ΔμH and higher Vo2 lead to more 
 production. Although ROS has been shown to have beneficial biological effects [29], 
over-production of ROS is detrimental due to its toxicity and ability to open the 
mitochondrial PTP [45]. In most cases, difference of several mM in  has been 
observed between the M146L-expressing and CTL cells (see Figures 5–7). Over extended 
periods, this difference will lead to damaging effects such as exacerbated Ca2+ homeostasis 
dysregulation and potentially cell death in M146L-expresing cells.
We took advantage of the robustness of the computational model to explore how changes in 
three main fluxes affect the overall amount of key variables of the mitochondria. By varying 
maximal flux rates of ANT, uniporter, and Na+/Ca2+ exchanger in this study we are able to 
see how the detrimental effects on mitochondria could be further exacerbated due to a range 
of normal to abnormal flux rates. The ANT, which controls the rate of ATP efflux from and 
ADP influx into the mitochondria shows interesting results as the rate is increased from a 
close-to-zero to a normally operational value. The PS mutant-expressing cell shows a 5 fold 
increase in the difference in ROS production. Also, the ATP in PS mutant-expressing cells 
shows as much as 4.8mM deficiency compared to control mitochondria at the same near 
zero ANT flux. The difference in [Ca2+]m shows little dependence on the rate of ANT, but 
still shows a significant difference in the two cases.
By changing Ca2+ flux through uniporter from almost zero to 10mM/s, we observe a 5 fold 
increase in the difference between the total [Ca2+]m and a near 38% increase in the 
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difference between the total  among control and M146L-expressing cells. At high 
Vunimax, the PS mutation causes a near 3mM deficiency in [ATP] compared to the CTL 
cells. On the other hand, changing the ability of mitochondria to release Ca2+ through 
Na+/Ca2+ exchanger causes the difference between different variables in CTL and M146L-
expressing cells to saturate because of the fixed Na+ concentration in the model. Even so, we 
see a near 12mM difference in the total  between the PS mutant-expressing and 
control cells. We also observe 4mM deficiency in [ATP] and 0.17mM higher total [Ca2+]m in 
M146L-expressing cells.
Dragicevic et al. [14] studied the effects of PS and APP mutations in multiple regions of the 
mice’s brain including cortical, hippocampal, stratal, and amygdalae. They measured 
respiration rates, ROS level, ΔΨm, and Cytochrome C oxidase activity and showed that 
mitochondria from cells expressing PS mutations were more impaired than those from 
mutant APP-ecpressing mice. Furthermore, mitochondria from mutant APP-expressing mice 
produced higher levels of ROS than those from control mice, but the highest levels of ROS 
production came from PS-mutant expressing mice. They observed double the amount of 
ROS in PS-mutant expressing mice from the cortex and hippocampus [14]. They also 
observed decreased ΔΨm in all 4 regions of the brain and higher Ca2+ uptake by 
mitochondria. These observations agree well with conclusions from our modeling study.
The close proximity of IP3R Ca2+ release channels at the ER to the uniporter in the 
mitochondria creates a local Ca2+ microdomain [35], in which Ca2+ concentrations can rise 
to a substantially higher level than in general cytosol during IP3R-mediated Ca2+ release. 
Evidence for fast Ca2+ uptake by the mitochondria have been reported in [15, 37]. It has also 
been reported that 90% of IP3R are located close to mitochondria and the majority of the 
uniporters sense the high Ca2+ in the microdomain [43]. Thus, the ER and mitochondria are 
spatially linked and their proximity to each other will dictate the influx of Ca2+ into the 
mitochondrial matrix. The higher open-probability of the IP3R in FAD-causing PS mutant-
expressing cells will lead to a significant [Ca2+]i increase in the Ca2+ microdomain. Higher 
IP3R Ca2+ release resulting in higher microdomain Ca2+ in FAD-causing PS-mutant-
expressing cells will subsequently exacerbate the impairment of mitochondrial function, 
which will be the subject of our future research.
Conclusion
In summary, we successfully fused experimental whole cell intracellular free Ca2+ 
concentration time traces recorded from cells expressing WT and mutant M146L PS1- 
expressing cells with a computational model to elucidate that how mitochondrial 
bioenergetics is affected in FAD cells. We show that the higher [Ca2+]i in M146L-expressing 
cells can lead to drastic differences between the overall production of key variables 
governing ATP and ROS production as compared to control cells, which could lead to cell 
death.
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Figure 1. 
Schematic representation of the mitochondrial physiological processes, metabolic energetics, 
ROS production, transport and scavenging incorporated in our model. The model takes into 
account TCA cycle dehydrogenases and enzymes. The TCA cycle of the mitochondrial 
matrix is fed by acetyl CoA (AcCoA), which oxidize fatty acids and glucose. The TCA 
cycle completes the oxidation of AcCoA to CO2 and produces NADH and FADH2, which 
are the driving force for the oxidative phosphorylation process. Activities of TCA cycle 
enzymes IDH and KGDH are explicitly dependent on Ca2+ in the matrix, which allows for 
the rate of Ca2+ uptake by mitochondria to be involved in membrane energization through 
the TCA cycle and the oxidative phosphorylation. As the NADH and FADH2 are oxidized 
by the respiratory chain, they drive the proton pumping across the inner membrane (VHE and 
VHE(f)) to establish an electrochemical gradient, or proton motive force (ΔμH) composed of 
the electrical gradient (ΔΨm) and proton concentration gradient (ΔpH). The proton motive 
force drives phosphorylation of matrix ADP to ATP by the F1F0 – ATPase (ATP synthase). 
The ΔΨm governs the electrogenic transport of ions, which includes the influx of Ca2+ 
through the uniporter, the Na+/Ca2+ exchanger and the adenine nucleotide translocator 
(ANT). The schematic shows the inner membrane ROS coupled kinematics. Superoxide 
anion  is transported through the inner membrane anion channel (IMAC) and [H2O2] is 
produced. See supporting information text for model equations and abbreviations not shown 
here.
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Figure 2. 
Time evolution of state variables. Showing the effects of [Ca2+]i uptake into the 
mitochondria matrix. Control (blue) and M146L (red) time traces of (A) experimentally 
measured [Ca2+]i, (B) [NADH], (C) [Ca2+]m, (D) [H2O2], (E) mitochondrial ROS ( ), 
(F) Cytoplasmic ROS ( ), (G) [ATP], and (H) ΔΨm.
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Figure 3. 
Time traces of various products in the TCA cycle as a function of Ca2+ uptake into the 
mitochondria matrix Control (blue) and M146L-expressing cell (red). (A) [ISOC], (B) 
[αkg], (C) [SCoA], (D) [Suc], (E) [FUM], (F) [MAL], and (G) [OAA].
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Figure 4. 
The rates of the oxygen consumption (Vo2) and the total rate of the three enzymes (VIDH, 
VKGDH, and VMDH) that determine the concentration of NADH in the TCA cycle. Effects on 
oxygen consumption (black) and total enzyme rate (green) in control cells (A) and M146L-
expressing cells (B). Rate of Vatpase as the changes in NADH occur due to uctuations in 
[Ca2+]i in CTL (C) and M146L-expressing cells (D).
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Figure 5. 
The difference in the mitochondrial main state variables in control and M146L- expressing 
cells as VmaxANT is varied. Difference (Δ) is defined as TotalML-TotalCTL. Difference in 
total: (A) ATP production, (B) Mitochondrial [Ca2+]m, (C) [H2O2], (D) , (E) , 
and (F) [NADH].
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Figure 6. 
The difference in the mitochondrial main state variables in control and M146L- expressing 
cells as Vmuni is varied. Difference in total: (A) ATP production, (B) Mitochondrial [Ca2+]m, 
(C) [H2O2], (D) , (E) , and (F) [NADH].
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Figure 7. 
The difference in the mitochondrial main state variables in control and M146L- expressing 
cells as VNaCaMax is varied. Difference in total: (A) ATP production, (B) Mitochondrial 
[Ca2+]m, (C) [H2O2], (D) , (E) , and (F) [NADH].
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